期刊文献+

系统性红斑狼疮患者合并动脉粥样硬化的发生率及相关危险因素分析 被引量:1

The Analysis of Incidence and Risk Factors for Atherosclerosis in Patients with Systemic Lupus Erythematosus
下载PDF
导出
摘要 目的:评估系统性红斑狼疮(SLE)合并动脉粥样硬化的发生率及相关危险因素。方法:采用颈动脉多普勒超声检测30例SLE病人(SLE组)及30名健康女性(对照组)颈部动脉粥样硬化斑块发生情况,并对其血清中总胆红素(TB)、尿酸(UA)、同型半胱氨酸(Hcy)等与SLE合并动脉粥样硬化之间的关系进行分析。结果:SLE组动脉粥样硬化的危险因素肥胖,尿酸、同型半胱氨酸的水平显著高于正常组,且SLE组中有斑块组这些危险因素的水平比无斑块组明显增高。结论:SLE患者并发动脉粥样硬化的发生率显著增高,而肥胖、尿酸、同型半胱氨酸则是可以反映SLE并发动脉粥样硬化的风险的相关危险因素。 Objective:To evaluate incidence and risk factors for atherosclerosis in patients with SLE. Methods:The prevalence of atherosclerotic plaque on the neck in 30 women with SLE and 30 healthy controls were examined by ultrasonography. The relation- ship between the atherosclerosis risk factors such as obesity, UA, Hcy and the atherosclerosis in patients with SLE was studied. Re- sults : SLE group atherosclerosis risk factors for obesity, UA, Hcy were significantly higher than normal group. And compared with the group without plaque, the levels of these risk factors of the plaque group in SLE group were increased significantly. Conclu- sion:The incidence of atherosclerosis in patients with SLE with is significantly increased. And risk factors such as UA, HCYmay reflect the risk of concurrent arterial atherosclerosis in SLE.
作者 陈芍
出处 《亚太传统医药》 2013年第9期88-90,共3页 Asia-Pacific Traditional Medicine
关键词 系统性红斑狼疮 动脉粥样硬化 危险因素 Systemic Lupus Erythematosus Atherosclerosis Risk Factors
  • 相关文献

参考文献9

二级参考文献55

  • 1中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5219
  • 2李金贤,徐新娟.高血压、颈动脉粥样硬化与脑卒中相关研究进展[J].心脏杂志,2007,19(3):354-356. 被引量:18
  • 3张春燕,吕良敬,鲍春德,李凤华,李红丽.系统性红斑狼疮与早发动脉粥样硬化及其相关危险因素[J].中华风湿病学杂志,2007,11(8):458-461. 被引量:17
  • 4CELLETTI F L,HILFIKER P R,GHAFOURI P,et al.Effect of human recombinant vascular endothelial growth factor 165 on progression of atherosclerotic plaque[J].J Am Coll Cardiol,2001,37:2126-2130.
  • 5UROWITZ M B,BOOKMAN A A,KORHLER B E,et al.The bimodal mortality pattern of systemic lupus erythematosus[J].Am J Med,1976,60:221-225.
  • 6JIMENEZ S,GAREIA-CRIADO M A,TASSIES D,et al.Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome[J].Rheumatology (Oxford),2005,44:756-761.
  • 7COLOMBO B M,CACCIAPAGLIA F,PUNTONI M,et al.Traditional and nontraditional risk factors in accelerated atherosclerosis in Systemic Lupus Erythematosus:role of vascular endothelial growth factor[J].Autoimmun Rev,2008,8(4):309-315.
  • 8MOULTON K S,HELLER E,KONERDING M A,et al.Angiogenesis inhibitors erdostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice[J].Circulation,1999,99:1726-1732.
  • 9Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol, 1997, 145: 408-415.
  • 10Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation, 1998, 97: 1837-1847.

共引文献35

同被引文献12

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部